Same dudes on here calling the elusive 'bounce'. Same guys calling it since $2.50. Same dudes saying way oversold. This thread is so predictable.
Every month they spend. Every month that cash balance capitulates. Very little revenue. Until revenue rises substantially, I'd stay clear of this. Unless you know the Product inside out and it's advantages over the competition then you'd be a massive risk taker buying. Fundamentals don't justify a buy. The cash backing argument is weak with this stock due to the high cash outflows on operational expenditure.
- Forums
- ASX - By Stock
- 1PG
- Where are the bots?
Where are the bots?, page-48
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1PG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online